Machine Learning Helps Predict Postpartum Hemorrhage Risk
Sema4 and Mount Sinai collaborated on two studies that demonstrate how machine learning can be used to improve postpartum hemorrhage risk prediction.
Read MorePosted by Chris Wolski | Nov 9, 2021 | Prenatal Testing |
Sema4 and Mount Sinai collaborated on two studies that demonstrate how machine learning can be used to improve postpartum hemorrhage risk prediction.
Read MorePosted by Chris Wolski | Nov 8, 2021 | Covid 19, Sequencing Systems |
Developed by UC San Diego researchers, the SENSR tool is based on CRISPR gene-editing technology that allows speedy detection of pathogens by identifying genetic sequences in their DNA or RNA.
Read MorePosted by Chris Wolski | Nov 5, 2021 | Colorectal |
Phillips-Medisize provides end-to-end manufacturing support to Exact Sciences, developers of the FDA-approved Cologuard at-home colorectal screening test.
Read MorePosted by Chris Wolski | Nov 5, 2021 | Sequencing Systems |
Whole genome sequencing from a single blood test picks up 31% more cases of rare genetic disorders than standard tests.
Read MorePosted by Chris Wolski | Nov 2, 2021 | Covid 19 |
AMP lays the foundation for a comprehensive national testing strategy that will promote better collaboration between laboratories and test manufacturers.
Read More